Conversion of water-soluble CBD to Δ9-THC in synthetic gastric fluid - an unlikely cause of positive drug tests
Cannabidiol (CBD) has been shown to convert to Δ9-tetrahydrocannabinol (Δ9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sod...
Gespeichert in:
Veröffentlicht in: | Journal of analytical toxicology 2023-09 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Cannabidiol (CBD) has been shown to convert to Δ9-tetrahydrocannabinol (Δ9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sodium dodecyl sulfate (SDS), due to limited solubility of CBD. Recently, water-compatible nano-emulsions of CBD have been prepared as a means of fortifying beverages and water-based foods with CBD. Since these emulsions contain surfactants as part of their formulation, it is possible that these preparations might enhance the production of Δ9-THC even in the absence of added surfactants. Three THC-free CBD products; an oil, an anhydrous powder, and a water-soluble formulation were incubated for 3 hours in SGF without SDS. The water-soluble CBD product produced a dispersion while the powder and the oil did not mix with the SGF. No THC was detected with the CBD oil ( |
---|---|
ISSN: | 1945-2403 |
DOI: | 10.1093/jat/bkad043 |